Search Results - L. D. Latyntseva
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
Legal and Medical Aspects of Off-Label Medication Use. Point of View by O. V. Tsygankova, T. I. Batluk, L. D. Latyntseva, D. Y. Platonov, N. M. Akhmedzhanov
Published 2019-03-01
Article -
5
-
6
-
7
Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fracti... by O. V. Tsygankova, N. E. Apartseva, L. D. Latyntseva, Ya. V. Polonskaya, E. V. Kashtanova
Published 2024-08-01
Article -
8
Potential new application points of SGLT2 inhibitors in patients with heart failure in combination with diabetes mellitus, non-alcoholic fatty liver disease and anemia (literature... by O. V. Tsygankova, O. V. Timoshchenko, O. V. Tuzovskaya, L. D. Latyntseva, K. Yu. Nikolaev
Published 2022-12-01
Article -
9
Analysis of polymorphism of innate immunity receptor genes in patients with coronary atherosclerosis and in a population sample from Novosibirsk by S. V. Mikhailova, D. E. Ivanoshchuk, P. S. Orlov, L. D. Latyntseva, E. V. Kashtanova, Ya. V. Polonskaya, Yu. I. Ragino, E. V. Shakhtshneider
Published 2023-08-01
Article